Immix Biopharma, Inc. financial statements
Immix Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 29.4M | 10-Q |
| Cash and equivalents | USD 93.93M | 10-Q |
| Total debt | USD 1.07M | EODHD |
Immix Biopharma, Inc. financials on 6ix · Immix Biopharma, Inc. on 6ix